"Global Controlled Release Drug Delivery Market, Drug Dosage, Price & Clinical Trial Insight 2026" Report Highlights:
• Global Controlled Release Drug Delivery Market: More Than US$ 70 Billion Opportunity by 2026 • US & Europe Market Share 2019: > 65% • US & Europe To Double It Market Sales Opportunity by 2026 • Number of Controlled Release Drug Available in Market: > 140 Drugs • Clinical Trials Insight by Company, Country, Indication & Patent: > 250 Drugs • Controlled Release Drugs Pricing, Patent & Dosage Insight • Global & Regional Trend Analysis, Future Market Opportunity Outlook • Global Controlled Drug Delivery Market Dynamics
The market established for the target patient segment focuses towards delivering drugs at a predetermined rate, systemically or locally for a specific period of time. Although the market is predominated by regular drugs but the continuous delivery of the drugs whose kinetics can be controlled is achieving a predictable growth curve. The market utilizes drug encapsulating devices which employ controlled release of the therapeutic agents ranging from days to months. The numerous advantages provided by market over traditional methods of drug delivery such as tailoring of rate of drug release, fragile drug protection and patient comfort and compliance is what changing the prescription pattern of the doctors towards controlled release drugs.
Extensions supplied to the available drug market in terms of mechanical strength, increasing demand of the patient population and novel drugs capable of achieving high drug loading are some of the factors that are considered as major driving factors for the controlled release drug delivery market. Other than the above mentioned factors, the market is coupled with reduced drug toxicity which is however estimated to boost the market growth in a short period of time.
In the last few years, increasing efforts have been delivered in order to diversify the range of the drug delivery and this has been processed by increasing the association of the researchers with the daily and unmet needs of the patient population. The availability of the controlled release drug delivery system in the market has shown a great progress towards handling the situation of the complex real world as the emergence of drugs that could not regulate the complex composition of disease was hampering with the overall growth of the drug market.
The availability of controlled release drugs in oral, injectable, nasal, topical and implantable forms for the patient population is making the market more dominant than the other available markets. The emergence of the market ended the search for the novel solutions to address the therapeutics challenges as well as has provided a great concern in the biotechnology and pharmaceutical industries. The amazing perspective lined up the way of controlled released drug market represents a more personalized and efficient delivery system in the coming years.
Although the platform that has been provided by the controlled release drug delivery market is novel but the drug delivery platform provided by market has been associated with impressive clinical pipeline. It carries the potential to treat a broad spectrum of disease such as infectious diseases, inflammatory diseases, autoimmune diseases, neurological diseases and several different types of cancer. The market is capable of offering a revolutionized treatment for the patients in order to truly modify the benefits that the patients were receiving from a long period of time.
According to the research conducted by the team, it is estimated that the market is availing safe and effective pharmacotherapeutic treatment regimen for the patient population that are in an urgent need of the drug delivery system capable of transforming their treatment schedule. Although the market is associated with significant challenges for the scientists and clinicians but the availability of technological drivers will be responsible for rapid discovery of drugs related to the market. The formulation changes and safety specifications coupled with the market is estimated to encourage the people towards its consumption. The optimistic landscape of the market guarantees the complete success of the market as well as a major competition for the drugs in the near future.
Our reports have been used by over 10K customers, including:
Forecasts by Technology (Oral Drug Delivery Therapy, Injectable Drug Delivery, Topical Drug Delivery, Pulmonary Drug Delivery, Implantable Drug Delivery, Ocular Drug Delivery, Others), by Indication (Infectious Diseases, Cancer, Cardiovascular Diseases, Diabetes, Respiratory Diseases, Central Nervous System Disorders, Others), by Distribution...
175 pages •
By The Business Research Company
• Sep 2021
Major players in the autoinjectors market are AbbVie, Mylan, Eli Lilly and Company, Amgen, Becton Dickinson and Company, Johnson & Johnson, Teva Pharmaceutical, Merck, Pfizer, Bayer, Biogen, and AstraZeneca. The global autoinjectors market is expected to grow from $2.42 billion in 2020 to $2.94 billion in 2021 at a compound annual growth...
United States Connected Drug Delivery Devices Market, By Product Type (Connected Sensors v/s Integrated Connected Devices), By Technology (Bluetooth, Near Field Communication, Others), By Application (Asthma & COPD, Diabetes, Others), By End User (Healthcare Providers v/s Homecare), By Region, Competition Forecast & Opportunities,...
The global isosorbide market exhibited moderate growth during 2015-2020. Also known as D-Isosorbide dinitrate, isosorbide (C6H10O4) is a bio-product obtained from starch. The derivatives of isosorbide, namely isosorbide dinitrate and isosorbide mononitrate, find extensive applications across various end use industries...
Report Scope This report analyzes the market trends of microneedles with data from 2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through the forecast period of 2021 to 2026). Regulatory scenarios, drivers, restraints and opportunities will be covered, as well as market shares for leading...
693 pages •
By IQ4I Research & Consultancy Pvt. Ltd
• Jul 2021
Drug Delivery Systems (DDS) are the advanced formulations or technologies that modulate the release profile of therapeutic or prophylactic agents, their absorption, distribution and elimination characteristics to achieve the desired therapeutic effect and enhance the safety profile, patient convenience and compliance to medications...
Drug Delivery Technologies: Market Size From $1,451.50 billion in 2020, the global Drug Delivery Technologies market is projected to reach $3,203.09 billion by 2028. Based on our analysis the market is expected to grow at a CAGR of 10.4% from 2020 - 2028 timeframe. Some of the prominent trends that the market...
Microspheres: Market Size From $5.62 billion in 2020, the global Microspheres market is projected to reach $12.96 billion by 2028. Based on our analysis the market is expected to grow at a CAGR of 11.0% from 2020 - 2028 timeframe. Some of the prominent trends that the market is witnessing include, emerging economies...
This report aims to provide a comprehensive study of the global market for transdermal drug delivery technologies/systems. It provides a detailed description of the different types of transdermal drug delivery systems (passive and active) and the current and historical market revenues.
539 pages •
By Roots Analysis Private Ltd.
• Jun 2021
Around 90% of the drug candidates in the current development pipeline and close to 40% of marketed pharmacological products, have been associated with concerns related to solubility and / or permeability. , In this context, considering modern regulatory standards, a large number of potential therapeutic leads...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.